DOI: 10.1055/s-00000134

Diabetologie und Stoffwechsel

References

Bonaca MP, Nault P, Giugliano RP. et al.
Low density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER Trial (further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk).

Circulation 2018;
137: 338-350

Download Bibliographical Data

Access:
Access: